Poor
Not Aligned
Patient Risk:
Moderate
Summary
Several claims about grapefruit/orange/lemon interactions, citrus effects, and monitoring are not supported by the provided label excerpts; multiple claims introduce specific guidance (e.g., oranges safe, oranges dose/monitoring, lemons no interaction, other citrus unknown/unknown interactions) that is absent or not stated. Some core mechanism/LDL-lowering and grapefruit-jucie interaction at high amounts are partially supported.
Category Scores
Accurate Statements
Lipitor (atorvastatin) is a statin medication.
Label identifies LIPITOR (atorvastatin calcium) as an HMG-CoA reductase inhibitor (Section 12.1).
Lipitor lowers low-density lipoprotein (LDL) cholesterol levels.
Label: LIPITOR indicated to reduce LDL-C (Section 1.2) and clinical studies state LIPITOR reduces LDL-C (Section 14.2).
Grapefruit or grapefruit juice can increase plasma concentrations of atorvastatin.
Section 7.2: Grapefruit Juice contains components that inhibit CYP3A4 and can increase plasma concentrations of atorvastatin.
Unsupported Statements
Lipitor works by reducing the production of cholesterol in the liver.
Mechanism is described as inhibition of HMG-CoA reductase (Section 12.1), but the provided excerpt does not specifically state 'reducing production of cholesterol in the liver.'
Grapefruit contains a compound called furanocoumarin that can inhibit the metabolism of Lipitor in the liver.
Provided label excerpt for grapefruit juice does not mention furanocoumarin or liver-specific metabolism details (Section 7.2 only states CYP3A4 inhibition and increased plasma concentrations).
Inhibition of Lipitor metabolism by grapefruit can lead to increased levels of Lipitor in the bloodstream.
Section 7.2 supports increased plasma concentrations, but the excerpt does not explicitly describe 'metabolism inhibition' phrasing or 'bloodstream' wording; only plasma concentrations with excessive grapefruit juice consumption are stated.
Increased levels of Lipitor in the bloodstream may cause side effects such as muscle weakness, fatigue, and liver damage.
Label excerpts mention myopathy/rhabdomyolysis and liver dysfunction, and postmarketing includes fatigue; however, the provided excerpts do not link grapefruit-induced increased concentrations to these specific side effects (this causality is not supported in the provided label text).
Oranges are generally considered safe to consume with Lipitor.
No orange-specific interaction safety statement appears in the provided label excerpts.
Orange juice contains a compound called naringenin that may affect the metabolism of Lipitor.
No orange juice/naringenin compound information appears in the provided label excerpts.
More research is needed to fully understand the extent of the interaction between orange juice and Lipitor.
Not stated in the provided label excerpts.
Lemons do not appear to interact with Lipitor.
No lemon-specific interaction information appears in the provided label excerpts.
Lemons can be safely consumed with Lipitor.
Not stated in the provided label excerpts.
There is limited research on interactions between other citrus fruits and Lipitor.
Not stated in the provided label excerpts.
Other citrus fruits and Lipitor have unknown interactions.
Not stated in the provided label excerpts.
Grapefruit or grapefruit juice should be avoided while taking Lipitor due to the potential interaction.
Label excerpt supports increased plasma concentrations, especially with excessive grapefruit juice consumption (>1.2 liters per day) (Section 7.2), but does not state a general 'avoid' instruction.
Orange juice consumption with Lipitor should be limited to small amounts and the body's response should be monitored.
No orange juice dosing limitation or monitoring guidance appears in the provided label excerpts.
Other citrus fruits such as limes, tangerines, or kumquats should be avoided in large quantities while taking Lipitor.
No label excerpt provided mentions limes/tangerines/kumquats or any avoidance guidance for these fruits.
It is recommended to consult a doctor or pharmacist before making changes to diet or medication regimen while taking Lipitor with citrus fruits.
No such counseling/recommendation statement is included in the provided label excerpts.
Contradictions
Low
AI Statement
Grapefruit or grapefruit juice should be avoided while taking Lipitor due to the potential interaction.
Label Reference
Section 7.2 indicates increased plasma concentrations especially with excessive grapefruit juice consumption (>1.2 liters per day) and does not provide a general 'should be avoided' directive.
Important Omissions
For grapefruit juice, the label specifies the threshold 'especially with excessive grapefruit juice consumption (>1.2 liters per day)'; the AI claims do not reflect this quantity-based specificity.
Importance:
Moderate
When discussing interactions, the label also emphasizes increased risk of myopathy with certain interacting drugs (e.g., fibric acid derivatives, niacin, cyclosporine, strong CYP3A4 inhibitors); the AI response focuses only on citrus fruits and does not mention these interaction drivers from the provided label excerpt.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Moderate
Overgeneralized guidance ('avoid grapefruit') and unsourced claims about oranges/lemons/other citrus could lead to inaccurate patient behavior. The label excerpt supports grapefruit juice increasing atorvastatin plasma concentrations (especially at high intake), but the AI adds multiple unsupported fruit-specific assertions and monitoring instructions.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Multiple citrus-fruit interaction and dietary guidance statements are not supported by the provided FDA label excerpts; grapefruit guidance is overgeneralized beyond the label's quantity-based framing.
Suggested Improvement
Limit interaction claims to what the label excerpt states: grapefruit juice contains components that inhibit CYP3A4 and can increase atorvastatin plasma concentrations, especially with excessive consumption (>1.2 liters/day). Remove fruit-specific assertions (oranges/lemons/other citrus) and any 'avoid/monitor small amounts' recommendations that are not present in the provided label text.